glutathione peroxidase glial cells and parkinson& 39

glutathione peroxidase glial cells and parkinson& 39 peroxidase-1 neuromodulation: Novel potentials of an old enzyme Pathogenesis of α-Synuclein in Parkinson's

Name: glutathione peroxidase glial cells and parkinson& 39 peroxidase-1 neuromodulation: Novel potentials of an old enzyme Pathogenesis of α-Synuclein in Parkinson's
Brand: southroadsurgery.com.au
SKU: 62354244289
Price: 27.32 USD
Availability: InStock
Rating: 4.6309000000000005 (15 reviews)

Pathogenesis of Synuclein in Parkinson's Disease: From a Neuron Glia Crosstalk Perspective Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease Glial cells improve Parkinson's disease by modulating neuronal function and regulating neuronal ferroptosis Frontiers Engineered inhalable nanocatalytic therapeutics for Parkinson's disease by inducing mitochondrial autophagy ScienceDirect Involvement of antioxidant enzymes in Parkinson's disease ScienceDirect Microglia, Astrocytes, and Oligodendrocytes in Parkinson's Disease: Neuroinflammatory Crosstalk and Emerging Therapeutic Strategies

SKU: 62354244289 · From southroadsurgery.com.au

4.6

USD27.32 USD75.32

Pay in 4 interest-free payments of $6.83 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

The survival rate was analyzed by the log-rank test p -values less than 0.05 were considered statistically significant

glutathione peroxidase glial cells and parkinson& 39 peroxidase-1 neuromodulation: Novel potentials of an old enzyme Pathogenesis of -Synuclein in Parkinson's

W.et al

Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, Jahoor F (2011) Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation